This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Formulating antitrust guidelines for API sector a key task of China's reform plan this year

( June 18, 2021, 02:30 GMT | Official Statement) -- MLex Summary: Formulating a set of antitrust guidelines for the active pharmaceutical-ingredients sector is among the key tasks of the Chinese government in deepening reforms of the country’s medical and healthcare systems this year, according to a notice issued by the State Council. The guidelines, drafted by the State Administration for Market Regulation, were released for public consultation in October last year.The text of the notice follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections